Conformationally Dynamic Peptide Probes for Amyloid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current peptide probes for detecting misfolded proteins associated with amyloidogenic diseases, such as Alzheimer's, have limitations in solubility, stability, and conformational change sensitivity, making them less effective in in vitro and in vivo applications.
Innovation Solution
Development of conformationally dynamic peptides with variant sequences that can adopt both random coil/alpha-helix and β-sheet conformations, featuring enhanced stability, solubility, and the ability to undergo detectable conformational changes upon binding to target proteins, labeled with fluorescent markers to signal binding events.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional peptide probes are used for detecting misfolded proteins, then detection capability is provided, but solubility and stability are insufficient
Solution Approach 1:
The patent modifies peptide sequences by introducing specific amino acid substitutions, additions, or deletions to alter the conformational dynamics and stability parameters of the peptide probes, enabling them to maintain structural integrity while detecting misfolded proteins effectively
Solution Approach 2:
The invention creates composite peptide structures combining multiple functional motifs (e.g., amyloid-binding sequences with conformational switches) to achieve both high detection reliability and improved stability through synergistic interactions between different peptide segments
2Reliability
If conventional peptide probes are used, then detection is possible, but conformational change sensitivity is limited
Solution Approach 1:
The patent employs conformationally dynamic peptides that can switch between different secondary structures (alpha-helix, beta-sheet, random coil) in response to binding events, providing enhanced sensitivity for detecting conformational changes in target proteins
Solution Approach 2:
The invention incorporates fluorescently labeled peptides that undergo conformational changes upon binding to misfolded proteins, resulting in detectable changes in fluorescence emission characteristics that enable precise measurement of conformational transitions
3Reliability
If conventional peptide probes are used, then detection function is provided, but solubility in aqueous solutions is poor
Solution Approach 1:
The patent introduces hydrophilic amino acid residues at specific locations within the peptide sequence to enhance aqueous solubility while maintaining the hydrophobic core regions necessary for amyloid binding, creating localized functional zones with different solubility characteristics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These peptides effectively detect target proteins with improved sensitivity and specificity, enabling early diagnosis and potential therapeutic interventions for amyloidogenic diseases by enhancing solubility, stability, and conformational change detection.
Implementation Method 1
the peptide probe adopts a β-sheet conformation upon binding to target protein exhibiting a β-sheet conformation or undergoes a change in conformation that generates a detectable signal
Implementation Method 2
the peptide probe is labeled with a detectable label, such as a fluorescent label, at the N-terminus, the C-terminus, both termini, or at one or more positions that generate a signal when the peptide adopts a β-sheet conformation or undergoes a conformation change upon binding to target protein
Data Source
AI summary
Disclosed are novel peptides that are useful, for example, for detecting target proteins having a β-sheet secondary structure which may be associated with a disease, and for diagnosing and treating such a disease. Related methods and kits also are disclosed.